Consolidated Statements of Stockholders' Deficit - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Stock Issuable [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2016	$ 5,590	$ 326,705	$ 16,000	$ 27,392,125	$ (29,558,609)	$ (1,818,189)
Balance, shares at Dec. 31, 2016	5,589,647	326,705,526
Net income (loss)					(202,678)	(202,678)
Balance at Dec. 31, 2017	$ 5,590	$ 326,705	16,000	27,392,125	(29,761,287)	(2,020,867)
Balance, shares at Dec. 31, 2017	5,589,647	326,705,526
Implementation of Revenue Recognition standard					51,148	51,148
Beneficial conversion features				93,000		93,000
Conversion of convertible debt		$ 3,000		(1,440)		1,560
Conversion of convertible debt, shares		3,000,000
Disposal of Medical Therapeutics subsidiary				3,036		3,036
Net income (loss)					918,238	918,238
Balance at Dec. 31, 2018	$ 5,590	$ 329,705	$ 16,000	$ 27,486,721	$ (28,791,901)	$ (953,885)
Balance, shares at Dec. 31, 2018	5,589,647	329,705,526